Does ATEZOLIZUMAB Cause Myelosuppression? 272 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 272 reports of Myelosuppression have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.8% of all adverse event reports for ATEZOLIZUMAB.
272
Reports of Myelosuppression with ATEZOLIZUMAB
0.8%
of all ATEZOLIZUMAB reports
22
Deaths
93
Hospitalizations
How Dangerous Is Myelosuppression From ATEZOLIZUMAB?
Of the 272 reports, 22 (8.1%) resulted in death, 93 (34.2%) required hospitalization, and 7 (2.6%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 272 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which ATEZOLIZUMAB Alternatives Have Lower Myelosuppression Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN